Fig. 1From: Risks of bleeding and thrombosis in intensive care unit patients with haematological malignanciesBleeding complications during ICU stay. No significant difference was seen in number of bleedings complications between the different diagnoses or in patients with haematopoietic stem cell transplantation (HSCT). ALL acute lymphoblastic leukaemia, MDS myelodysplastic syndrome, AML acute myeloid leukaemiaBack to article page